Vittry formulation 1 oily solution
Combined vitamin drug for prevention and treatment of hypovitaminosis and associated diseases
100 ml glass bottle, 1 l, 100 ml and 20 ml polymeric bottle packed in carton.
- Optimal physiological oil-soluble vitamin content.
- Safe and effective drug to normalize metabolism.
- Potential use for both treatment and prevention.
- Convenient and available dispension and package. No special storage conditions are required for this drug.
Chemical composition and pharmacological propertiesVittry is a vitamin medication containing combined physiological vitamin content (А, D3, Е). Components provide synergistic effect on dogs and cats presenting in metabolism normalization.
Vittry is manufactured in two dosage forms: oral (Vittry formulation 1) and injectable (Vittry formulation 3) ones which vary by vitamin quantity.
1 ml of Vittry formulation 1 for oral use contains vitamin A - 15,000 IU, vitamin D3 - 20,000 IU, vitamin Е - 10 mg, as well as excipient (vegetable oil).
1 ml of Vittry formulation 3 solution for injections contains vitamin A – 30,000 IU, vitamin D3 - 40,000 IU, vitamin Е - 20 mg, as well as excipient (vegetable oil).
IndicationsPrevention and treatment of canine and feline hypovitaminosis, rachitis, osteomalacia, toxic hepatic dystrophy, dermatitis, sluggish wounds and ulcers, tetania, encephalomalacia, xerophthalmia and mucosal catarrhal inflammations. The drug increases viability of puppies and kittens.
Dosage and administrationVittry formulation 1: oral use with feeding, every day within 2-3 months. dogs - 2-4 drops, cats - 1-2 drops. Treatment: a dose may be multiplied by three. Overdose symptoms are not detected in animals.
Administer Vittry formulation 3 injectable intramusculary or subcutaneously: dogs - 0.25-0.5 ml, cats - 0.15 ml. Prevention: once in 2-3 weeks. Treatment: once in 7-10 days.
Vittry formulations 1 and 3 are compatible with other drugs, feedings and feed supplements.